REQUEST A DEMO
Total
USD $0.00
Search more companies

Gn Neutriceuticals Sdn. Bhd. (Malaysia)

Main Activities: Pharmaceutical and Medicine Manufacturing | Pharmacies and Drug Stores
Full name: Gn Neutriceuticals Sdn. Bhd. Profile Updated: February 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Gn Neutriceuticals Sdn. Bhd. is an enterprise in Malaysia, with the main office in Subang Jaya. It operates in the Pharmaceutical and Medicine Manufacturing sector. The company was established on December 18, 2003. In 2022, the company reported a net sales revenue increase of 2.53%. Its total assets decreased by 9.26% over the same period. The net profit margin of Gn Neutriceuticals Sdn. Bhd. increased by 4.61% in 2022.

Headquarters
No.17, Jalan Tp3, Sime Uep Industrial Park
Subang Jaya; Selangor; Postal Code: 47620

Contact Details: Purchase the Gn Neutriceuticals Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Gn Neutriceuticals Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Gn Neutriceuticals Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Gn Neutriceuticals Sdn. Bhd. report to view the information.
Incorporation Date:
December 18, 2003
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
52.94%
Purchase this report to view the information.
47.06%
Company Performance
Financial values in the chart are available after Gn Neutriceuticals Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
2.53%
Total operating revenue
2.53%
Operating profit (EBIT)
26.81%
Net Profit (Loss) for the Period
33.74%
Total assets
-9.26%
Total equity
34.1%
Operating Profit Margin (ROS)
5.06%
Net Profit Margin
4.61%
Return on Equity (ROE)
-0.1%
Quick Ratio
1.08%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?